Mustang Bio and City of Hope Announce Initiation of Phase 1 Clinical Trial of MB-101 (IL13Rα2-specific CAR T cells) to Treat Leptomeningeal Brain Tumors
Trial underway at City of Hope to evaluate safety and feasibility of administering therapy in patients with brain tumors such...